Author

A. Verderosa

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell signaling & trafficking· 2 Research Focus:drug response / drug discovery· 2 Organism:E. coli· 2 Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Assay:bulk RNA-seq· 1 Research Focus:chromatin & epigenetic regulation· 1 Organism:mouse· 1

Frequent Co-Authors

B. Zhang· 2 shared A. Bebes· 1 shared A. Farbos· 1 shared A. R. Jeffries· 1 shared B. Housden· 1 shared B. M. Invergo· 1 shared G. Tolle· 1 shared J. Cronan· 1 shared

Activity by Year

2022-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

B. Zhang

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Heterogeneous efflux pump expression underpins phenotypic resistance to antimicrobial peptides

K. K. Lee, U. Lapinska, G. Tolle, M. Micaletto, B. Zhang, W. Phetsang, A. Verderosa, B. M. Invergo, J. Westley, A. Bebes, R. Yuecel, P. A. ONeill, A. Farbos, A. R. Jeffries, S. van Houte, , S. Pagliara

This study shows that subpopulations of stationary phase bacteria resist antimicrobial peptides through enhanced efflux and other mechanisms, and suggests combining tachyplesin with sertraline to combat resistance.

bioRxiv · Apr 22, 2024Microbiology

Loss of β-ketoacyl acyl carrier protein synthase III activity restores multidrug-resistant Escherichia coli sensitivity to previously ineffective antibiotics

Y. Hong, J. Qin, A. Verderosa, S. Hawas, B. Zhang, M. A. T. Blaskovich, J. Cronan, M. Totsika

This study shows that disrupting the FabH gene in E. coli reduces its resistance to antibiotics by compromising the cell envelope, making previously ineffective antibiotics effective again.

bioRxiv · Feb 18, 2022Microbiology